teva. i want to buy, buy, buy. i want to buy, buy, buy. i want to buy, buy, buy. how about frank in oregon? frank. >> caller: hey, boo-yah to all of you at cramerica. how are you guys doing? >> not bad. i hope the oregon employment comes back. used to be the greatest employment state in the union. not anymore. how can i help? >> caller: i'm looking at thc. >> i thought it should have gone up more on monday. i think we got out of 5, came back in, i think the stock can go to 7. hospitals are big beneficiaries, so are hospital real estate investment trusts. i don't want scm. that turned out to be a bad one. that's select med. that's disappointing. let's go to ernesto in florida. ernesto? >> caller: the first 10 days of the last 20 seemed to lead the pack. now kind of flat. do i need to worry? i like aig a lot. but i want to make sure i'm not going to get into something -- >> what is that? what stock? what stock? aig? i don't like it. they owe too much money to the government. the stock itself doesn't represent the actual company. they should not have done this revers

of course, teva being the largest generic company, as many of these units in the pharma piece, anywaye going to be dispensed via generic drugs, teva sells more pills than merck and pfizer combined so they clearly should be a beneficiary. on the device side we like medtronic and in pharma it's probably all beaten out at this point, for growth investors our favorite stock with be bristol. and financial stories based on value would be pfizer and merck. i think the biggest influence for pfizer and merck, quite frankly, is the direction of the economy. if we do get a fierce recovery, then, you know, pfizer and merck are not going to keep pace. if the market moves to being more defensive, then those stocks would certainly be favored. >> any conflicts of things that youown, or get your disclosures? >> so deutsche bank, i would assume, you know, in our asset management group, owns all of these stocks. i would think that our investment bankers are always looking for business from all of these stocks. and i've no material nonpublic information on any of them, either. >> thanks, barbara. >> than

teva as a historic high. biogen up half a percent. carl icon has increased his stake in game maker take two interactive to nearly 14%. that stock is up 3% right now. finally, shares